Imago BioSciences, Inc. Quarterly Liabilities and Equity in USD from Q4 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Imago BioSciences, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2020 to Q3 2022.
  • Imago BioSciences, Inc. Liabilities and Equity for the quarter ending September 30, 2022 was $186M, a 21.4% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $186M -$50.8M -21.4% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $196M +$111M +130% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $212M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $225M +$126M +127% Dec 31, 2021 10-Q 2022-11-09
Q3 2021 $237M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $85.2M Jun 30, 2021 10-Q 2021-08-19
Q4 2020 $98.9M Dec 31, 2020 10-K 2022-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.